NUP98/JARID1A is a novel recurrent abnormality in pediatric acute megakaryoblastic leukemia with a distinct HOX gene expression pattern

S Arentsen-Peters, JF Van Galen, H Berna Beverloo… - Leukemia, 2013 - nature.com
Cytogenetic abnormalities and early response to treatment are the main prognostic factors in
acute myeloid leukemia (AML). Recently, NUP98/NSD1 (t (5; 11)(q35; p15)), a …
被引用次数：158 相关文章

NUP98/JARID1A is a novel recurrent abnormality in pediatric acute megakaryoblastic leukemia with a distinct HOX gene expression pattern

JDE de Rooij, I Hollink, S Arentsen-Peters… - Leukemia, 2013 - go.gale.com
Cytogenetic abnormalities and early response to treatment are the main prognostic factors in
acute myeloid leukemia (AML). Recently, NUP98/NSD1 (t (5; 11)(q35; p15)), a …

[引用][C] NUP98/JARID1A is a novel recurrent abnormality in pediatric acute megakaryoblastic leukemia with a distinct HOX gene expression pattern

JDE de Rooij, I Hollink, S Arentsen-Peters… - Leukemia, 2013 - cir.nii.ac.jp
NUP98/JARID1A is a novel recurrent abnormality in pediatric acute megakaryoblastic
leukemia with a distinct HOX gene expression pattern | CiNii Research CiNii 国立情報学 …
[PDF] core.ac.uk

[PDF][PDF] NUP98/JARID1A is a novel recurrent abnormality in pediatric acute megakaryoblastic leukemia with a distinct HOX-gene expression pattern

JDE de Rooij, IHIM Hollink… - … IN PEDIATRIC ACUTE …, 2013 - core.ac.uk
Cytogenetic abnormalities and early response to treatment are the main prognostic factors in
acute myeloid leukemia (AML). Recently, NUP98/NSD1, a cytogenetically cryptic fusion, was …

NUP98/JARID1A is a novel recurrent abnormality in pediatric acute megakaryoblastic leukemia with a distinct HOX gene expression pattern

JDE de Rooij, I Hollink, S Arentsen-Peters… - …, 2013 - pubmed.ncbi.nlm.nih.gov
Cytogenetic abnormalities and early response to treatment are the main prognostic factors in
acute myeloid leukemia (AML). Recently, NUP98/NSD1 (t (5; 11)(q35; p15)), a …

NUP98/JARID1A is a novel recurrent abnormality in pediatric acute megakaryoblastic leukemia with a distinct HOX gene expression pattern.

JD de Rooij, IH Hollink, ST Arentsen-Peters… - Leukemia, 2013 - europepmc.org
Cytogenetic abnormalities and early response to treatment are the main prognostic factors in
acute myeloid leukemia (AML). Recently, NUP98/NSD1 (t (5; 11)(q35; p15)), a …
[PDF] researchgate.net

[PDF][PDF] NUP98/JARID1A is a novel recurrent abnormality in pediatric acute megakaryoblastic leukemia with a distinct HOX gene expression pattern

JDE de Rooij, I Hollink, S Arentsen-Peters… - Leukemia, 2013 - researchgate.net
Acute myeloid leukemia (AML) is a heterogeneous disease characterized by recurrent
genetic aberrations. 1–3 At present, survival rates in pediatric AML are approximately 60 …
[PDF] eur.nl

[PDF][PDF] NUP98/JARID1A is a novel recurrent abnormality in pediatric acute megakaryoblastic leukemia with a distinct HOX-gene expression pattern

JDE de Rooij, IHIM Hollink… - … IN PEDIATRIC ACUTE …, 2013 - repub.eur.nl
Cytogenetic abnormalities and early response to treatment are the main prognostic factors in
acute myeloid leukemia (AML). Recently, NUP98/NSD1, a cytogenetically cryptic fusion, was …

NUP98/JARID1A is a novel recurrent abnormality in pediatric acute megakaryoblastic leukemia with a distinct HOX gene expression pattern.

JDE de Rooij, I Hollink… - Leukemia …, 2013 - search.ebscohost.com
Cytogenetic abnormalities and early response to treatment are the main prognostic factors in
acute myeloid leukemia (AML). Recently, NUP98/NSD1 (t (5; 11)(q35; p15)), a …

NUP98/JARID1A is a novel recurrent abnormality in pediatric acute megakaryoblastic leukemia with a distinct HOX gene expression pattern

J de Rooij, I Hollink, S Arentsen-Peters, J van Galen… - Leukemia, 2013 - repub.eur.nl
Cytogenetic abnormalities and early response to treatment are the main prognostic factors in
acute myeloid leukemia (AML). Recently, NUP98/NSD1 (t (5; 11)(q35; p15)), a …